Home shots vs. hospital drips: IBD treatment convenience study
NCT ID NCT07123350
Summary
This study looks at patients with Crohn's disease or ulcerative colitis who are switching from receiving their vedolizumab medication through intravenous (IV) infusions at a clinic to giving themselves subcutaneous (SC) injections at home. Researchers will review the medical records of about 120 patients to see how well they do on the home injections, what dosing patterns doctors use, and whether the switch helps control their disease. The goal is to provide better information for doctors and patients considering this more convenient treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37211, United States
Conditions
Explore the condition pages connected to this study.